US Patent Issued to KING'S COLLEGE LONDON on Jan. 27 for "B cell targeted parallel car (pCAR) therapeutic agents" (British Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,507, issued on Jan. 27, was assigned to KING'S COLLEGE LONDON (London).

"B cell targeted parallel car (pCAR) therapeutic agents" was invented by John Maher (London) and Leena Halim (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are immuno-responsive cells expressing a B cell targeting pCAR comprising a 2nd generation chimeric antigen receptor (CAR) and a chimeric co-stimulatory receptor (CCR). Also provided herein are methods of preparing the immuno-responsive cells and methods of directing T cell mediated immune response using the immuno-responsive cells."

The patent was filed on Aug. 28, 2020, under Application No. 17/638,...